Viewing nowCombinationBardipin Tablet 5/160 mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Pamgen Science Co., Ltd.

MFDS item code 201308486 · Approved 2013.07.30 · Insurance code 670103430
Treatment of essential hypertension not adequately controlled with monotherapy
This medication is used in patients with essential hypertension for whom blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Exercise caution when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients who are allergic to the active ingredients, are pregnant, or are breastfeeding, as well as in patients with severe renal or liver impairment. In patients who are deficient in sodium or fluids, hypotension may occur, so the condition should be confirmed before starting, and careful monitoring is required at the start of treatment. Frequent monitoring of potassium levels is necessary in patients with high potassium levels or those taking medications that can raise potassium levels. Patients with kidney problems, those who have received kidney transplants, or those with a history of angioedema require special caution when taking this medication, and it should be discontinued immediately if symptoms of angioedema occur. Patients with heart failure or post-myocardial infarction should have their renal function closely monitored while taking this medication, as pulmonary edema and other symptoms may occur. This medication may cause dizziness or fatigue while driving or operating machinery, so caution is required. Overdosage can cause hypotension or heart-related problems, so it is essential to adhere to the prescribed dosage and consult medical staff immediately if any abnormal symptoms occur. This medication may interact with other antihypertensive agents, potassium supplements, and certain anti-inflammatories, so it is crucial to inform your healthcare provider of any other medications being taken. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. The safety and efficacy of this medication in children under 18 years of age have not been sufficiently established, so its use is not recommended. Older adults may be administered the same dosages as general adults; however, their condition should be monitored closely. Adverse reactions during treatment may include headache, dizziness, edema, rash, gastrointestinal disturbances, etc., so if symptoms are severe or persistent, medical staff should be notified.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory decrease, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitation, sensory decrease, Stevens-Johnson syndrome, hypotension, dizziness, reflex tachycardia, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air, and it is best stored at room temperatures between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
Dark yellow oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Pamgen Science Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.